The abstract is read at the publisher; the summary is JClub's.
In temozolomide-treated U251 glioma cells, a Src-activated EGFR–TBK1 axis drives autophagic mitochondrial recycling, enabling emergence of the resistant population.
- Why it matters: Secondary chemotherapy resistance is a multi-step process with unclear mechanisms, and mitochondrial changes during the transition from sensitivity to resistance remain poorly defined.
- What they did: The team performed an unbiased, longitudinal proteomic analysis of U251 cells across drug-sensitive, tolerant, and resistant states, then used genome editing, PROTAC-mediated targeted protein degradation, and inhibitors with single-cell and microscopic assays.
- The result: They found an early stress marked by a transient peak of reactive oxygen species, after which mitochondrial quality control supports stress resolution and the emergence of resistance via EGFR/TBK1-dependent autophagic recycling.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.